# Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

> **NCT04772729** · PHASE4 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 77 (estimated)

## Conditions studied

- Diabetes type1
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin faster aspart (Fiasp, Novo Nordisk)

## Key facts

- **NCT ID:** NCT04772729
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04772729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04772729, "Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04772729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*